GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 3B BlackBio Dx Ltd (BOM:532067) » Definitions » COGS-to-Revenue

3B BlackBio Dx (BOM:532067) COGS-to-Revenue : 0.27 (As of Mar. 2024)


View and export this data going back to 1996. Start your Free Trial

What is 3B BlackBio Dx COGS-to-Revenue?

3B BlackBio Dx's Cost of Goods Sold for the three months ended in Mar. 2024 was ₹61.8 Mil. Its Revenue for the three months ended in Mar. 2024 was ₹230.0 Mil.

3B BlackBio Dx's COGS to Revenue for the three months ended in Mar. 2024 was 0.27.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. 3B BlackBio Dx's Gross Margin % for the three months ended in Mar. 2024 was 73.11%.


3B BlackBio Dx COGS-to-Revenue Historical Data

The historical data trend for 3B BlackBio Dx's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

3B BlackBio Dx COGS-to-Revenue Chart

3B BlackBio Dx Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.46 0.23 0.39 0.29 0.29

3B BlackBio Dx Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 0.28 0.35 0.28 0.27

3B BlackBio Dx COGS-to-Revenue Calculation

3B BlackBio Dx's COGS to Revenue for the fiscal year that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=218.421 / 741.247
=0.29

3B BlackBio Dx's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=61.842 / 229.98
=0.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


3B BlackBio Dx  (BOM:532067) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

3B BlackBio Dx's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 61.842 / 229.98
=73.11 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


3B BlackBio Dx COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of 3B BlackBio Dx's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


3B BlackBio Dx (BOM:532067) Business Description

Traded in Other Exchanges
N/A
Address
7-C, Industrial Area, Govindpura, Bhopal, MP, IND, 462023
3B BlackBio Dx Ltd is one of the leading Indian companies in the field of PCR-based Molecular Diagnostic Kits. The Company is ISO 13485:2016 certified, GMP-compliant biotech R&D organization, as an Indo-Spanish JV company and engaged in the design, development, manufacturing and commercialization of PCR based Molecular Diagnostic kits, PCR Enzymes & PCR Reagents.

3B BlackBio Dx (BOM:532067) Headlines

No Headlines